Workflow
联影医疗(688271):推出新一轮股权激励 彰显业绩增长信心

Core Viewpoint - The company has announced a new stock incentive plan for 2025, aimed at enhancing employee motivation and aligning their interests with long-term business growth, with a focus on core business development [2]. Group 1: Stock Incentive Plan - The company plans to grant 5 million restricted stocks at a price of 95 yuan per share to 1,368 individuals, including senior management and key technical personnel [1]. - This new incentive plan adds to the previous two rounds launched in 2023 and 2024, bringing the total number of stocks involved in all active incentive plans to 11.6219 million, approximately 1.41% of the current total share capital [2]. - The performance assessment indicators for the incentive plan are based on revenue growth targets for 2025-2027, with goals of 20% annual growth and trigger values of 16% for each year [2]. Group 2: Market Position and Financial Performance - The company has initiated the 2025 medical equipment update, with a strong performance in bidding for public medical institutions, securing 336 projects worth a total of 5.41 billion yuan, which represents 15.96% of the national market for medical imaging equipment [3]. - The company is expected to benefit significantly from the new round of equipment updates and the acceleration of overseas market expansion, driving quarterly performance recovery and achieving the 20% revenue growth target [3]. - Revenue forecasts for 2025-2027 are projected at 12.366 billion, 14.836 billion, and 17.755 billion yuan, with year-on-year growth rates of 20.05%, 19.98%, and 19.67% respectively [3].